Sinopharm
1099.HK
#2186
Rank
โ‚น778.35 B
Marketcap
โ‚น249.42
Share price
0.10%
Change (1 day)
20.86%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น214.74 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น214.74 Billion a decrease over its 2023 earnings that were of โ‚น297.68 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น214.74 B-27.86%
2023โ‚น297.68 B-0.73%
2022โ‚น299.87 B-1.72%
2021โ‚น305.11 B11.7%
2020โ‚น273.14 B18.44%
2019โ‚น230.61 B10.85%
2018โ‚น208.05 B3.05%
2017โ‚น201.89 B36.48%
2016โ‚น147.93 B7.11%
2015โ‚น138.11 B12.38%
2014โ‚น122.90 B25.05%
2013โ‚น98.28 B22.54%
2012โ‚น80.20 B35.43%
2011โ‚น59.22 B52.24%
2010โ‚น38.90 B30.99%
2009โ‚น29.69 B60.59%
2008โ‚น18.49 B48.29%
2007โ‚น12.47 B123.29%
2006โ‚น5.58 B